Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 503 across all filing types
Latest filing 2026-04-07 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialized and rematerialized for the quarter ended March 31, 2026. It is addressed to stock exchanges and requests to take the information on record. The document is short (1596 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements.
2026-04-07 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialized and rematerialized for the quarter ended March 31, 2026. It is addressed to stock exchanges and requests to take the information on record. The document is short (1596 characters) and is a compliance certificate rather than a full financial report or detailed filing. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related certificate.
2026-04-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication from Vikas Lifecare Limited to the stock exchanges (NSE and BSE) regarding the closure of the trading window for insiders ahead of the announcement of financial results for the quarter and financial year ending March 31, 2026. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations and informs about the trading restrictions period. The document does not contain any financial data, results, or detailed report but is an announcement related to trading restrictions before financial results are declared. The document length is short (2545 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication from Vikas Lifecare Limited to the stock exchanges (NSE and BSE) regarding the closure of the trading window due to pending unaudited financial results for certain quarters and the fiscal year. It references prior intimations and states that the trading window will remain closed until 48 hours after the financial results are made publicly available. There is no actual financial data, report, or detailed analysis included in the document. The document is essentially an announcement or notification related to compliance and trading restrictions, not a financial report or earnings release. The document length is short (2439 characters), and it serves as an intimation to the stock exchanges rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance-related filings that do not fit other categories.
2026-03-30 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a media release from Vikas Lifecare Limited dated February 7, 2026, addressed to the National Stock Exchange of India and BSE Limited. It announces that the company's website has been temporarily taken offline due to a cyber-attack and outlines the preventive technical review measures being taken. The document is a public announcement of an operational issue and does not contain any financial data, regulatory certifications, voting results, or management changes. It is not a report, transcript, or detailed presentation but a compliance disclosure under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is 5560 characters, which is sufficient for a detailed announcement but does not constitute a full report or financial filing.
2026-02-07 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement (2023 characters) from Vikas Lifecare Limited addressed to stock exchanges (NSE and BSE) regarding the postponement of a Board Meeting originally scheduled for February 7, 2026. It informs that the unaudited financial results for certain periods (quarter and half year ended September 30, 2025, and quarter and nine months ended December 31, 2025) will be considered and approved at a future Board Meeting, the date of which will be intimated later. There are no actual financial statements or detailed financial data included in this document. The document is essentially an update on the scheduling and outcome of a Board Meeting related to financial results, but it does not contain the results themselves. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not qualify as an Interim/Quarterly Report (IR) or Earnings Release (ER) because it lacks substantive financial data. It is also not a Board/Management Information (MANG) filing since it does not announce changes in board or management personnel.
2026-02-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.